These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

608 related items for PubMed ID: 7707396

  • 1. Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.
    Fogler WE, Pearson JW, Volker K, Ariyoshi K, Watabe H, Riggs CW, Wiltrout RH, Longo DL.
    J Natl Cancer Inst; 1995 Jan 18; 87(2):94-104. PubMed ID: 7707396
    [Abstract] [Full Text] [Related]

  • 2. Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody.
    Pearson JW, Fogler WE, Volker K, Usui N, Goldenberg SK, Gruys E, Riggs CW, Komschlies K, Wiltrout RH, Tsuruo T.
    J Natl Cancer Inst; 1991 Oct 02; 83(19):1386-91. PubMed ID: 1681110
    [Abstract] [Full Text] [Related]

  • 3. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
    Sela S, Husain SR, Pearson JW, Longo DL, Rahman A.
    J Natl Cancer Inst; 1995 Jan 18; 87(2):123-8. PubMed ID: 7707383
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.
    Rybak SM, Pearson JW, Fogler WE, Volker K, Spence SE, Newton DL, Mikulski SM, Ardelt W, Riggs CW, Kung HF, Longo DL.
    J Natl Cancer Inst; 1996 Jun 05; 88(11):747-53. PubMed ID: 8637029
    [Abstract] [Full Text] [Related]

  • 5. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U, Walther W, Shoemaker RH.
    J Natl Cancer Inst; 1996 Oct 02; 88(19):1383-92. PubMed ID: 8827016
    [Abstract] [Full Text] [Related]

  • 6. Regression of established tumors expressing P-glycoprotein by combinations of adriamycin, cyclosporin derivatives, and MRK-16 antibodies.
    Watanabe T, Naito M, Kokubu N, Tsuruo T.
    J Natl Cancer Inst; 1997 Apr 02; 89(7):512-8. PubMed ID: 9086008
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance.
    Naito M, Tsuge H, Kuroko C, Koyama T, Tomida A, Tatsuta T, Heike Y, Tsuruo T.
    J Natl Cancer Inst; 1993 Feb 17; 85(4):311-6. PubMed ID: 7678867
    [Abstract] [Full Text] [Related]

  • 8. Restoration of interferon alpha potentiation of a recombinant ricin A chain immunotoxin following cytoreduction of xenografts of advanced ovarian tumors.
    Pearson JW, Fogler WE, Volker K, Riggs CW, Gruys E, Groves ES, Wiltrout RH, Longo DL.
    J Natl Cancer Inst; 1993 Jun 02; 85(11):907-12. PubMed ID: 8492319
    [Abstract] [Full Text] [Related]

  • 9. Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance.
    Vredenburg MR, Ojima I, Veith J, Pera P, Kee K, Cabral F, Sharma A, Kanter P, Greco WR, Bernacki RJ.
    J Natl Cancer Inst; 2001 Aug 15; 93(16):1234-45. PubMed ID: 11504769
    [Abstract] [Full Text] [Related]

  • 10. Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo.
    Stein U, Walther W, Lemm M, Naundorf H, Fichtner I.
    Int J Cancer; 1997 Sep 04; 72(5):885-91. PubMed ID: 9311609
    [Abstract] [Full Text] [Related]

  • 11. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice.
    Chou TC, Guan Y, Soenen DR, Danishefsky SJ, Boger DL.
    Cancer Chemother Pharmacol; 2005 Oct 04; 56(4):379-90. PubMed ID: 15875185
    [Abstract] [Full Text] [Related]

  • 12. Possibility of the reversal of multidrug resistance and the avoidance of side effects by liposomes modified with MRK-16, a monoclonal antibody to P-glycoprotein.
    Matsuo H, Wakasugi M, Takanaga H, Ohtani H, Naito M, Tsuruo T, Sawada Y.
    J Control Release; 2001 Nov 09; 77(1-2):77-86. PubMed ID: 11689261
    [Abstract] [Full Text] [Related]

  • 13. [Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16, and their synergistic modulation of multidrug resistance].
    Naito M, Tsuruo T.
    Gan To Kagaku Ryoho; 1994 Feb 09; 21(3):395-402. PubMed ID: 7906507
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of reversing effect of cyclosporin A on vincristine resistance by anti-P-glycoprotein monoclonal antibody MRK-16.
    Naito M, Tsuge H, Kuroko C, Tomida A, Tsuruo T.
    Jpn J Cancer Res; 1993 May 09; 84(5):489-92. PubMed ID: 8100562
    [Abstract] [Full Text] [Related]

  • 15. In vivo imaging and specific targeting of P-glycoprotein expression in multidrug resistant nude mice xenografts with [125I]MRK-16 monoclonal antibody.
    Scott AM, Rosa E, Mehta BM, Divgi CR, Finn RD, Biedler JL, Tsuruo T, Kalaigian H, Larson SM.
    Nucl Med Biol; 1995 May 09; 22(4):497-504. PubMed ID: 7550027
    [Abstract] [Full Text] [Related]

  • 16. Biochemical modulation of 'classical' multidrug resistance by BIBW22BS, a potent derivative of dipyridamole.
    Jansen WJ, Pinedo HM, Kuiper CM, Lincke C, Bamberger U, Heckel A, Boven E.
    Ann Oncol; 1994 Oct 09; 5(8):733-9. PubMed ID: 7826906
    [Abstract] [Full Text] [Related]

  • 17. Expression behavior of 85-kDa membrane protein in adriamycin-resistant tumor cells and the inhibition of human tumor growth in athymic mice by MRK-20 monoclonal antibody against the protein.
    Ishii S, Naito M, Tsuruo T.
    Jpn J Cancer Res; 1993 Jul 09; 84(7):776-82. PubMed ID: 8370652
    [Abstract] [Full Text] [Related]

  • 18. Biochemical and pharmacological characterization of MCF-7 drug-sensitive and AdrR multidrug-resistant human breast tumor xenografts in athymic nude mice.
    Mimnaugh EG, Fairchild CR, Fruehauf JP, Sinha BK.
    Biochem Pharmacol; 1991 Jul 05; 42(2):391-402. PubMed ID: 1677569
    [Abstract] [Full Text] [Related]

  • 19. Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenografts.
    Broxterman HJ, Feller N, Kuiper CM, Boven E, Versantvoort CH, Teerlink T, Pinedo HM, Lankelma J.
    Int J Cancer; 1995 Jun 09; 61(6):880-6. PubMed ID: 7790125
    [Abstract] [Full Text] [Related]

  • 20. P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs.
    Shabbits JA, Mayer LD.
    Mol Cancer Ther; 2002 Jan 09; 1(3):205-13. PubMed ID: 12467215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.